|
Friday
September 28, 2001
•
Biacore Acquires An Exclusive License to Axiom Biotechnologies'
Cell-Based Platform Technology
•
Genomic Solutions Updates Financial Expectations
• Myriad
to roll out Melaris
Thursday
September 27, 2001
•
Cellzome
Acquires GlaxoSmithKline's Cell Map Unit
• Xerion
Pharmaceuticals hires new CFO
• Myriad Genetics to Launch MELARIS™ - a Predictive Medicine
Test For Melanoma
•
Caliper
Forms Amphora to Provide Chemical Genomics Information, Products
And Services to Speed Drug Discovery Using LabChip® Technology
•
Nobel
Laureate Joins GeneProt Scientific Advisory Board
• PerkinElmer Acquisition of Packard BioScience
Approved
•
Merck
and Compaq Executives to Keynote Region's Largest Biotechnology
Investor Conference, MASS Opportunities
•
Entelos
Add to Management Team in In Silico R&D
•
Outsourcing
Protein Therapeutics Conference to Be Held October 15-16 In Princeton,
NJ
Wednesday
September 26, 2001
•
Packard
BioScience Actively Pursues Protein Array Market With Launch of HydroGel™
Coated Slides
•
Micralyne
and Signature Announce Research and Development Agreement
• LSBC's CEO talks to The Wall Street Transcript
• Caliper
aims to put drug research labs on chips
• MelTec Appoints CFO
Tuesday
September 25, 2001
• Structural GenomiX-Funded Undulator Beamline Operational
in November 2001
•
The
Proteomics Payoff -TechnologyReview.com
•
Millennium
Becomes First Customer For Biacore's New High Performance Analytical System
•
BIO
VentureForum 2001: Unprecedented Array Of Biotech Entrepreneurs, Venture
Capitalists
• CuraGen's CEO Jonathan Rothberg Talks to The Wall Street
Transcript
Monday
September 24, 2001
• OGS Interim Results for the Six Months Ended 30 June 2001
•
3-Dimensional
Pharmaceuticals Announces Webcast Of Presentation At Bear Stearns
Health Care 'Virtual' Conference
Friday
September 21, 2001
• Intrinsic Bioprobes and Bruker Daltonics Announce
Strategic Collaboration
•
Bio-Rad
to Resume Common Share Stock Purchase Program
Thursday
September 20, 2001
• Proteome Systems and Protagen Enter Into Proteomics
Collaboration
• LSBC
Expands Gene and Protein Analysis Methods with Animal Viral Nucleic Acids
Patent
• ISB Receives Grant to Boost Proteomics Effort -GenomeWeb
•
Structural
GenomiX and Compaq to Build Multi-Million Dollar State-of-the-Art
Data Center for Structural Informatics
•
Kinexus
Bioinformatics Launch a New Website and a New Proteomics Service
•
Myriad
Reports Advanced Pre-Clinical Progress With Anti-HIV Drug
•
3-Dimensional
Pharmaceuticals Receives Patent Protection For Novel Protease Inhibitors
Associated With Blood Clotting
Wednesday
September 19, 2001
• MediChem Announces Corporate Restructuring Plan And Staff
Reductions
•
Genomic
Solutions to Benefit From GlaxoSmithKline and Cartesian
Technology Accord
• Biotechs Chart Steady Course as Massachusetts Biotech Council
Preps for Annual 'MASS Opportunities' Investor Conference
•
Protein
Kinases Conference to Feature Latest Research Advances in Newark, NJ,
October 15-16, 2001
• MDS Reports Third Quarter Results
• Bio-warfare counter measures become investor focus (Bruker)
Tuesday
September 18, 2001
•
Maxygen Creates Novel Protein Activity for New Market Opportunities
• Signature Receives Two Basic Patents for MCS Technology
• Zyomyx Appoints New Senior Vice President & Chief Business
Officer
•
Bruker
Wins $10M DOD Contract to Provide Ion Trap Mass Specs for Biological Defense
-GenomeWeb
Monday
September 17, 2001
• The Scripps Research Institute Awards Syrrx Exclusive
License To XtalView Software
•
EUROPROTEOME
announced Completion of its oversubscribed Û 9.5 Million Financing Round
•
BIO
VentureForum 2001 to Showcase 89 Leading Life Sciences Investment Opportunities
• LSBC Authorizes Common Stock Repurchase
• Air Travel Disruptions Force Postponement of Genomics and
Proteomics Conferences
•
GeneData,
Bayer Extend Collaboration for Three Years -GenomeWeb
•
Syrrx Awarded Exclusive License to ScrippsÕ X-ray Crystallography
Software -GenomeWeb
Thursday
September 13, 2001
• Pfizer Contributes to Relief Efforts in New York City
•
American
Heart Association to Contribute American Heart Walk Funds to Fallen
Firefighters
Wednesday
September 12, 2001
• United Way Sets Up The September 11th Fund
•
Novartis
Donates $3 Million to American Red Cross To Help Those Suffering as a
Result of Terrorist Attacks
• Abbott Laboratories Fund Provides Financial Support to Relief
Efforts
•
Albertson's,
Inc. and American Red Cross Launch National Fundraising Effort On Behalf
of Victims of U.S. Attacks
•
America's
Blood Centers Given Clearance to Ship Blood To the Greater New York Area
•
Genzyme
Saddened by Death of Lisa J. Raines In Crash of American Airlines
Flight 77
• Pfizer Will Reopen Manhattan World Headquarters on Thursday,
September 13th
Tuesday
September 11, 2001
• MDS Appoints IBM Executive to Board
•
IGEN Presents Four New High-Throughput Screening Tests
•
Patented
Peptide Containing 'Cholesterol Fingerprint' Which Binds Cholesterol Licensed
to Samaritan by Georgetown University
• In Search for Cures, Quark Seeks to Eliminate Research
Bottleneck -GenomeWeb
Monday
September 10, 2001
• GPC Biotech Announces Issuance of Two Patents for Anti-fungal
Drug Discovery Program (See
Patent 6,271,197: Assays and reagents for identifying anti-fungal agents,
and uses related thereto; 6,277,564:
Assays and reagents for identifying anti-fungal agents, and uses related
thereto)
•
CRS Proteomics Platform Eliminates 2D Gel Bottlenecks
• Caliper Launches New LabChip® High Throughput Screening
System
• Incyte and Galapagos Genomics to Collaborate in Gene Function
Studies
•
Bio
IT, a Computational Drug Discovery Company, Raises US $7.8 Million
Friday
September 7, 2001
• Genomic Solutions Announces Initiative to Achieve Profitability
in 2002; Genomic
Solutions to Acquire Cartesian Technologies
•
Genomic
Profiling Systems, Inc. Makes Debut Presentation at the Emerging Medical
Technology East Conference
• Locus Discovery Raises $28 Million in First Close of Series
D Equity Financing; May Raise up to an Additional $12 Million in a Second
Close
• Treading the Thin Ice of Proteomic Patent Protection -GenomeWeb
Thursday
September 6, 2001
•
Myriad
Discovers Novel Hepatitis 'C' Target
•
Structural Bioinformatics and ChemNavigator Sign Proteomics
Agreement
• New
Protein Extraction Patent Expands Development and Biomanufacturing Potential
for LSBC (See
Patent 6,284,875: Method for recovering proteins from the interstitial
fluid of plant tissues)
•
Progenics
and Cytogen Develop Novel Prostate Cancer Vaccine in Collaboration
With AlphaVax
• Full Structure of Key Protein May Lead to Next Generation
of Cancer Drugs
•
ProMetic
Announces Up-Date on Financing
• Entelos Raises $25 Million in Series C Financing
• Structural Genomix Picks Compaq for Structural Informatics
Systems -GenomeWeb
•
BioBridge
Completes PIUMS Project; Partner AstraZeneca Collects First Unit
-GenomeWeb
Wednesday
September 5, 2001
•
MediChem
and Rigel Pharmaceuticals Enter into Structural Proteomics Agreement
Focused on Ubiquitin Ligases
•
Array
BioPharma and Vertex Establish Drug Discovery Agreement; Collaboration
to Focus on Discovering Novel Drugs Targeting Phosphatases
Tuesday
September 4, 2001
• Xantos Biomedicine and Xerion agree to collaborate
in further research of two newly discovered apoptosis genes
•
GeneData
and diaDexus Collaborate on the Discovery of Disease Markers Through
Functional Genomics Data Analysis
•
Evotec
OAI and Novartis Sign Licence and Technology Agreement for
On-Bead Screening
• The Society for Biomolecular Screening Awards Promega
Scientist For Innovation; High Throughput Screening Award Celebrates 'Twinkles
in the Night'
•
ProMetic
Announces a Financing of $6,575,000
Thursday
August 30, 2001
• Thermo Electron and Bruker Daltonics Settle Ion Trap
Patent Litigation
Wednesday
August 29, 2001
• Biacore's Report January - September, 2001 Brought Forward
One Day
•
ProMetic Announces its Results for the Q2 Ending June 30, 2001
•
Baxter
Bioscience to Present Breakthrough Manufacturing Strategies at Outsourcing
Protein Therapeutics Conference, Oct 15-16 Princeton, NJ
• Protein Kinases Conference & Expo to be held in Newark,
NJ, October 15-16, 2001
Tuesday
August 28, 2001
• GPC Biotech Appoints Steven Lazar as Worldwide Head of Intellectual
Property
•
Physiome
Sciences Licenses PathwayPrism™ Biological Modeling Technology
to 3rd Millennium for the Development of Models for Huntington's
Disease
Monday
August 27, 2001
•
Accelrys
Helps Accelerate Drug Design Through MedChem Explorer 2.0, Debuts Discovery
Studio™
•
MDS Completes Integration of Life Sciences Businesses
• Advanced
Drug Discovery Technologies Push High-Throughput Screening Markets To
$3.5 Billion
Friday
August 24, 2001
•
125
Registered Delegates to Date, 175+ Anticipated to Attend Microarray Technologies
Conference & Expo on September 24-25, Princeton, NJ
•
Study:
Human Genes Undercounted -Wired.com
Thursday
August 23, 2001
•
Accelrys Delivers Annotations of 89% of Human Proteome to Consortium
Members
• GeneProt
Licenses DoubleTwist's Genomic Databases and Tools for Its Proteomic
Research
• Europroteome
Licenses the Rosetta Resolver Gene Expression Data Analysis System
•
Luminex
and Hitachi Announce Distribution and Agency Agreement For Japan
•
Millennium
to Present Breakthrough Manufacturing Strategies at Outsourcing Protein
Therapeutics Conference, Oct 15 - 16 Princeton, NJ
Wednesday
August 22, 2001
•
OGS Announces Grant of Expanded High-Throughput Proteomics Patent
(See
Patent 6,278,794: Computer-assisted isolation and characterization of
proteins)
• IBM Collaborates on Supercomputer (Blue Gene) -Wired.com
• ORNL,
IBM Pooling Talents to Examine Diseases
• Sequitur Licenses Functional Genomics Technology to Rigel
Pharmaceuticals
•
Biotech's
Best: Good Mutations -Forbes.com
• Galapagos Genomics and Vertex in Gene Function Collaboration
Tuesday
August 21, 2001
•
Thermo
Finnigan, Proteome Systems Enter Into Strategic Technology
and Research Partnership
•
OGS
announces completion of New Drug Application submission for Vevesca™
(OGT 918) with the US Food and Drug Administration
• Myriad Reports Fiscal 2001 Year-End Results
•
Myriad,
biotech stocks slip back -CBS MarketWatch.com
•
Protein
Kinases Conference & Exposition to be Held In Princeton, NJ, October 15-16,
2001
Monday
August 20, 2001
•
Genetix Group Announces Further Strengthening of Its Scientific Advisory
Board
• Genomics Investment Burns Bright in Void of Dot-Com Retreat
-GenomeWeb.com
Friday
August 17, 2001
•
GeneProt Appoints CFO, VP of Intellectual Property, and CTO, Geneva
Branch
• SG
Cowen downgrade weighs on Millennium and Celera
Thursday
August 16, 2001
•
Proteome
Systems and the Buck Institute for Age Research initiate program
on the proteomics of aging
•
MDS
Pharma Enhances Scientific Capabilities With API 4000 LC/MS/MS System
• Genomic Solutions New Web Site Complements Company's Branding
Strategy
•
Biogen
Research Reported in 'Science' Signals Important New Drug Target
•
After
wallowing, life sciences back in style -The Boston Globe
Wednesday
August 15, 2001
•
MDS
and Signature Form Strategic Alliance to Develop and Commercialize
Novel Drug Discovery Instrumentation
•
Compaq
to Provide High-Performance Computing for Entelos' Virtual Laboratory
Environment
Tuesday
August 14, 2001
•
Array
and ICOS Establish Drug Discovery Collaboration Exploiting A Novel
Chemical Proteomics Platform
•
Brilliant
Future for Proteomics Business as Market Revenues Soar to $5.6 Billion
By 2006
•
GPC Biotech Announces Successful Results for the First Half of 2001
•
MorphoSys
Announces Q2 Results
• Decision
Resources Report Identifies Opportunities Generated by Trends in Genomics
Dealmaking
• TKT
Awarded Broad Patent Relating to Production and Delivery of Proteins
• Cell
Robotics' Reports Q2 Results Workstation Sales Growth Related to Stem
Cell, Animal Cloning and Functional Genomics Research
Monday
August 13, 2001
• DiscoveRx
and Applied Biosystems Collaborate to Market New HTS Products
• Blackstone
Technology Group Is Now Blackstone Computing
• Thermo
Electron Displays Product Breadth at DDT 2001
• IBM
and Physiome Sciences Announce Supercomputing And Biological Modeling
Partnership; Physiome
Sciences Launches PathwayPrism™ Technology Platform
• 150+
to Attend Microarray Technologies & Biochips Conference & Expo on September
24-25, Princeton, NJ
• Vertex
Installs State-of-the-Art Supercomputer to Accelerate Drug Discovery
Friday
August 10, 2001
•
Caliper Announces Organizational Change
• Eureka! IP Treasure Could be Right Under Your Nose -GenomeWeb.com
Thursday
August 9, 2001
•
Prolinx Releases New Products for Proteomics Applications
•
Genomic
Solutions Rat P450 Pre-Printed Microarray Improves Screening of Metabolic
Enzymes
• Lynx and Phytera Announce First Milestone in Functional
Genomics Collaboration
• Genetica
Identifies Key Protein in RNAi Complex for Silencing Genes
• Incoming Whitehead Director Looks to Usher Institute
Beyond Sequencing -GenomeWeb.com
Wednesday
August 8, 2001
•
MediChem Confirms Financial Results for Second Quarter 2001
• Genomics
Collaborative and ActivX Sign Proteomics Discovery Program
in Colon Cancer
• Caliper Announces Hiring of Vice President, Sales and Marketing
•
Maxygen
to Webcast Q2 2001 Earnings Conference Call On August 14, 2001
Tuesday
August 7, 2001
•
Scientific American Hosts BioSilico 2001: The Strategic Summit
on In Silico Bio
•
Cytogen
Reports Q2 2001 Results
• Bruker Daltonics Q2 2001 Product Revenue Up 31%
• Prolinx
to be featured on World Business Review: On Location
• New Study Links Glucose/Protein Complexes (A.G.E.s) and
Alzheimer's Disease
•
Odyssey
Pharmaceuticals Awarded Key Patent for Platform Technology
Monday
August 6, 2001
• Automated
Cell Raises $2.6 Million for Protein Function Development
•
Cell
Genesys and GPC Biotech Report Positive Preclinical Results
For Cardiovascular Gene Therapy for Restenosis
•
Biacore
Launches New System to Dramatically Reduce Drug Discovery and Development
Bottlenecks
•
MediChem
Announces the Appointment of New Directors to Emerald BioStructures Structural
Proteomics Unit
•
MDS
Pharma Names New Site Manager in Beijing
Friday
August 3, 2001
•
Packard
BioScience Company Announces Second Quarter 2001 Results
•
Helix
BioMedix in Negotiations to License Novel Anti-Infective Peptides
From University of British Columbia
• ARIAD
Reports 2001 Q2 Results
Thursday
August 2, 2001
• Novartis
Agreement with Compugen to Speed Completion of Novartis Human Protein
Database
•
MediChem to Report Q2 Financial Results
•
Caliper
Announces Q2 Financial Results
• First Application on Luminex's LabMAP™ Technology
Receives Approval From FDA
•
Deltagen
Enters Into a Secreted Protein Agreement With Lilly
•
Myriad
Names New Senior VP and Head of Development
•
Incyte's
LifeSeq Gold® Database Wins Scientific Computing & Instrumentation's
Readers' Choice Award
Wednesday
August 1, 2001
• PerkinElmer
signs deal with Nonlinear Dynamics for global distribution rights
to analysis software for Proteomics
•
InforMax Announces 2Q Revenue and Net Loss Per Share Results
• MediChem
Announces Extension of Collaboration With Bristol-Myers Squibb
•
Corvas
International to License Incyte LifeSeq® Gold Database
Online to Study Role of Serine Proteases in Cancer
Tuesday
July 31, 2001
•
Integrative Proteomics has raised $25 million in its second round
of financing
• AP
Biotech and Nonlinear Dynamics Announce Proteomics Software
Distribution Agreement
• Institute for Systems Biology Enters Partnership With Supercomputing
Center
•
Genomic
Solutions Reports Q2 Results
• ABI and Bruker Daltonics Go Head-to-Head for MALDI
TOF/TOF Market -GenomeWeb.com
• InforMax Announces GenoMax License Agreement With Windber
Research Institute
Monday
July 30, 2001
•
Genomic
Solutions Collaborates with ProteoMetrics to Create New Generation
of Bioinformatic Research Tools
•
ProteoMetrics in Acquisition Talks with Genomic Solutions
-GenomeWeb.com
• MDS
Proteomics Unveils Targeted, High-Speed Protein Identification
•
MorphoSys
Achieves Second Milestone in GPC Biotech Collaboration ; Immunosuppressive
Effect Shown in Animal Models
•
Prospect
Venture Partners Closes $500M Fund
•
Zyomyx
and BD Biosciences Collaborate to Apply Antibody Expertise to High
Density Protein Biochips
• UCLA Researchers to Build Expanded Database of Protein Interaction
Information -GenomeWeb.com
Friday
July 27, 2001
• Team
of Boston Scientists Solve Structure of Actin
• InforMax
Q2 2001 Financial Results Conference Call
• ACLARA Announces Q2 2001 Financial Results
•
OGS
Completes Installation of Proteomics Machine -GenomeWeb.com
Thursday
July 26, 2001
•
Yeast
Proteome Published -Bio.com
•
Deltagen Acquisition of Arcaris Extends Research Efforts Into
Functional Proteomics
• Celera
Genomics Reports Q4 and Fiscal 2001 Year End Results
• Applied
Biosystems Reports Q4 and Fiscal 2001 Year End Results
• Celera
loss widens, Applied Biosystems profit falls
• Bio-Rad
Reports Continued Increase in Profits
•
3-Dimensional
Pharmaceuticals Announces Financial Results for the Quarter and Six
Months Ended June 30, 2001
• Sensium Technologies Expands License to Protein Biochip
Technology -GenomeWeb.com
•
CuraGen
Reports Q2 2001 Financial Results
• Luminex
Reports Strong Q2 Results
•
Ciphergen
Reports Q2 2001 Financial Results
•
Vertex
Reports Q2 and First Half 2001 Financial Results
•
Lynx
Webcast at the Virtual Biotechnology Stocks Forum July 27
Wednesday
July 25, 2001
•
OGS Announces Development of 2nd Generation Proteomics Platform
•
LSBC
Reports 2001 Q2 Financial Results
• Locus Discovery Assembles One of the Most Powerful Supercomputers
in the World
•
Cellomics
Announced Today That Vertex Has Purchased an ArrayScan® HCS
•
Cytogen
to Report Q2 Results and Host Investor Call On August 7, 2001
•
Solutions
to Capacity Shortfall Featured at Outsourcing Manufacturing of Protein
Therapeutics Meeting, October 15-16 in Newark, NJ
•
BTG
Acquires New Cost-Effective Protein Production Method
•
Antigenics
and Mass General to Test Heat Shock Protein-Based Approach to HIV
•
ProMetic
and Genzyme Transgenics Collaboration Gains Further Momentum
• Compugen
Reports Q2 Financial Results
Tuesday
July 24, 2001
•
Accelrys and Sun Create Three Dimensional Proteome Map for
Neisseria Meningitidis
• Bruker
Daltonics to Webcast Q2 Conference Call on August 8, 2001
•
Abgenix
and CuraGen Scientists Discover and Select Additional 49 Novel
Antibody Drug Targets for Development
• IBC To Hold 6th Annual World Congress On Drug Discovery
Technology
Monday
July 23, 2001
• Caliper
and NASA Establish Collaboration to Create Macromolecular Crysrtal
in Space using LABCHIP¨ Technology
• Hybrigenics
to apply its functional proteomics technology on OGS' disease associated
target candidates
• Applera
Announces Conference Call to Review Next Phase of Genomics Strategy
•
Biacore
Half-Year Report January - June 2001; Biacore's
Analysts' Conference Call - Clarification
• Applied
Precision Signs a Distributor of arrayWoRx(e) Biochip Reader in Korea;
in
United Kingdom
• Compugen
Licenses Gencarta™ Database to Albert Einstein College of Medicine
and Weizmann Institute of Science
Friday
July 20, 2001
•
IBM
To Build Life Sciences Supercomputer for Korea Institute
•
Scimagix
Secures $25 Million Funding Company; Strengthens Leadership in Image Informatics
• Frost
& Sullivan to Hold Analyst Briefing on Proteomics Industry July 26,
2001
•
Incyte
CEO Speaks Out on Beating Celera at its Own Game
•
NCI
and FDA to Expand Proteomics Research into Clinical Studies
-GenomeWeb.com
•
Genomic
Solutions to Hold Conference Call July 31, 2001
•
Microarray
Technologies Conference to Follow on Success of Genomic Technologies Conferences
Held July 16-18 in Princeton, NJ
•
Outsourcing
Manufacturing of Protein Therapeutics Conference to be Held October 15
- 16 in Newark, NJ
Thursday
July 19, 2001
•
GPC
Biotech and MorphoSys Achieve Milestone In Cancer Antibody
Program
•
Structural GenomiX Adds Two Board Members
•
Ciphergen
Conference Call and Webcast
•
Incyte
Reports Financial Results Up 22% for Q2 Fiscal 2001
• Celera
Signs 5 Academic Institutions to the Celera Discovery System
•
PIERIS
Proteolab AG Appoints CEO - The Anticalin™ Company
Wednesday
July 18, 2001
•
AxCell
Biosciences Announces New Effort to Meet Growing Demand for Proteomics
Data in Drug Discovery and Other Research
•
Lynx
Reports Financial Results for Q2;
Extends Technology License to BASF-LYNX Bioscience AG
•
Phylos
Significantly Broadens Its Patent Portfolio For Its Profusion™ Technology
Platform See
Patent (6,258,558: Method for selection of proteins using RNA-protein
fusions)
•
BioMicro
Systems Receives U.S. Patent Allowance For Microfluidic Passive Fluid
Control Technology
•
Myriad
Board of Directors Approves Stockholder Rights Plan;
issues rights plan with 15 percent trigger
•
Vertex
Announces the Completion of its Acquisition of Aurora
•
Discovery
Partners and MAXIA Announce Successful Completion of Drug Discovery
Collaboration and Commencement of New Project
Tuesday
July 17, 2001
•
Proteome Society Calls for Speakers for September Meetings
•
GPC
Biotech Announces Issued Patent on Antibodies For Detecting p27 Cell
Cycle Protein See
Patent (6.242,575: Antibodies for detecting p27 protein)
• MediChem
expects lowered Q2 results
• Compugen
Licenses Gencarta™ Database to Kyowa-Hakko
Monday
July 16, 2001
•
Leading
Scientists to Discuss the Future of the Human Proteome Project
At Seattle Proteomics Conference
•
Isis
GeneTrove Division Signs Deal With Celera To Functionalize More
Than 200 Novel Human Genes
• Signature
Acquires Cambridge Discovery Chemistry, Inc. From Millennium
•
UPDATE:
PerkinElmer Agrees to Acquire Packard BioScience, Posts
Strong Life Science Revenue Growth -GenomeWeb.com
Friday
July 13, 2001
•
Genome
Schmenome -- Why The Genome Is Overrated -Plastic.com
•
After
the Genome, What Then? by Richard Lewontin -NYBooks.com
•
ProteoMetrics
Management Gears Up for Growth
• OGS Initiates Vevesca™ Clinical Study At New York
University
Thursday
July 12, 2001
•
InforMax
and AxCell to Host Asia Pacific Seminar Series 'High-Throughput
Research™: Integrating Genomics, Expression, and Proteomics for Accelerated
Discovery Research
•
Luminex Schedules Q2 Earnings Release
• Baxter
to Further Increase Manufacturing Capacity for Therapeutic Proteins
•
New
European Bioinformatics Institute Research Director Named -GenomeWeb.com
Wednesday
July 11, 2001
• SYNSORB
Biotech Inc. Receives Additional Milestone Payment From MDS Proteomics
•
Cubist
CEO Appointed to MDS Proteomics Board of Directors
• Applied
Biosystems and Celera Financial Results to be Released July
26, 2001
•
Harvard
Publication Says Soy Protein Reduces Cholesterol When 20 to 50 Grams Daily
Consumed
•
Outsourcing
Protein Therapeutics Conference To Be Held October 15-16 in Newark, NJ
• PerkinElmer
Signs Global Distribution Agreement with Nonlinear Dynamics for
Proteomics Image Analysis Software
•
With
Support of GSK, Canadian Researchers Launch New Proteomics Study
-GenomeWeb.com
Tuesday
July 10, 2001
•
ProteomWeaver
excels at software contest
•
ActivX
Names New Chairman and CEO; Completes
$20 Million Private Placement
• Applied
Biosystems Makes Preliminary Report On Q4 2001 Revenues
• Syn
X, Genzyme ink new deal for stroke test
• Bruker
Daltonics Added to the Russell 2000 Index
• Celera's
New Deal: Good News, Bad News -Forbes.com
•
Caliper
Among Presenting Companies at the 11th Bay Area Biotechnology Stocks Forum
July 27 & 28
Monday
July 9, 2001
•
Signature Closes $43 Million Series D Financing Round
•
Luminex Announces Research and Development Initiative
•
Change
of Expression For proteomics predictions, mRNA transcripts won't do -TheScientist.com
• Bruker
Daltonics Reports Strong Q2 Life-Science Systems Bookings
• Incyte
and Secant Announce Partnership to Market and Further Develop The
Genomics Knowledge Platform
Friday
July 6, 2001
• New
Patent Strengthens LSBC's Competitive Advantage in Automated Proteomics
Technology See
Patent (6,245,206: Automated system for two-dimensional electrophoresis)
• Nymox
AlzheimAlert Protein "An Excellent Biomarker" for Alzheimer's
Disease According to New Scientific Publication
Thursday
July 5, 2001
•
Incyte
Sets Announcement Date for Q2 Fiscal 2001 Earnings Release
• Genomic
Solutions Updates Financial Expectations
Wednesday
July 4, 2001
•
Enzyme
therapy effective against genetic defect
•
Japan Looks to Niche Markets to Gain Piece of Microarray, Biochip
Pie -GenomeWeb.com
Tuesday
July 3, 2001
•
Jain
PharmaBiotech releases the 7th edition of "Proteomics - Technologies
and Commercial Opportunities"
• Netherlands
Research Council Signs Database Subscription Agreement With Celera
• Inpharmatica
Successfully Completes 31.25 Million British Pounds of Fund Raising
Monday
July 2, 2001
•
Biotech
Financing Window Reopens: Capital Keeps Pouring In, Especially From Venture
Capitalists
•
Thermo Electron Completes First Phase of Thermo Ecotek Sale for $238
Million
• U
of Alabama (Birmingham) Subscribes to DoubleTwist's Annotated
Human Genome Database and Tools
• MelTec
Announces New Technology for High-Throughput Topological Analysis of Human
Cells
•
German
Proteomics Company Publishes Paper Detailing Use of Proprietary Fingerprinting
Technology -GenomeWeb.com
|
